| Ticker Details |
Masimo Corporation Common Stock
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
|
| IPO Date: |
August 8, 2007 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$9.34B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.30 | 1.42%
|
| Avg Daily Range (30 D): |
$0.25 | 0.14%
|
| Avg Daily Range (90 D): |
$1.35 | 0.97%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.45M |
| Avg Daily Volume (30 D): |
1.37M |
| Avg Daily Volume (90 D): |
1.16M |
| Trade Size |
| Avg Trade Size (Sh.): |
71 |
| Avg Trade Size (Sh.) (30 D): |
61 |
| Avg Trade Size (Sh.) (90 D): |
60 |
| Institutional Trades |
| Total Institutional Trades: |
9,164 |
| Avg Institutional Trade: |
$5.27M |
| Avg Institutional Trade (30 D): |
$12.28M |
| Avg Institutional Trade (90 D): |
$9.95M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$8.19M |
| Avg Closing Trade (30 D): |
$35.68M |
| Avg Closing Trade (90 D): |
$25.01M |
| Avg Closing Volume: |
65.15K |
|
|
| Financials |
| |
TTM |
FY 2025 |
Q3 2026 |
|
Basic EPS
|
|
$-2.83
|
$-1.86
|
|
Diluted EPS
|
|
$-2.8
|
$-1.84
|
|
Revenue
|
|
$1.53B
|
$371.5M
|
|
Gross Profit
|
|
$945.2M
|
$230.6M
|
|
Net Income / Loss
|
|
$-151.5M
|
$-100.4M
|
|
Operating Income / Loss
|
|
$310M
|
$83.6M
|
|
Cost of Revenue
|
|
$581.7M
|
$140.9M
|
|
Net Cash Flow
|
|
$-28.1M
|
$118.3M
|
|
PE Ratio
|
|
|
|
|
|
|